CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novo Nordisk As - ADR Company Snapshot
Novo Nordisk As operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other companies in this sector in the United States: Abbott Laboratories (2016 sales of $20.85 billion of which 33% was Nutritionals), Allergan plc ($14.57 billion of which 41% was US Medical Aesthetics), and Bristol-Myers Squibb Company ($19.43 billion of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2016, sales at Novo Nordisk As were $16.58 billion. This is an increase of 3.9% versus 2015, when the company's sales were $15.96 billion. This was the fifth consecutive year of sales increases at Novo Nordisk As (and since 2011, sales have increased a total of 33%). Sales of Diabetes Care saw an increase of 4.2% in 2016, from $12.66 billion to $13.19 billion.
   
   
 
  Stock Performance Chart for Novo Nordisk As - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 42.98
(Figures in U.S. Dollars)
1 Week 2.3%   13 Weeks -0.5%  
4 Weeks 20.2%   52 Weeks -22.0%  
 
Novo Nordisk As - ADR Key Data:
  Ticker: NVO Country: United States
  Exchanges: NYSE FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 16,575,856,200
(Year Ending Jan 2017).
Employees: 41,971
  Currency: U.S. Dollars Market Cap: 84,537,222,229
  Fiscal Yr Ends: December Shares Outstanding: 1,966,896,748
  Share Type: B Stamaktie Closely Held Shares: 138
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.